We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · September 13, 2021

Veliparib With Platinum-Based Chemotherapy for First-Line Treatment of Advanced Squamous Cell Lung Cancer

Journal of Clinical Oncology

 

Additional Info

Journal of Clinical Oncology
Veliparib in Combination With Platinum-Based Chemotherapy for First-Line Treatment of Advanced Squamous Cell Lung Cancer: A Randomized, Multicenter Phase III Study
J. Clin. Oncol 2021 Aug 26;[EPub Ahead of Print], SS Ramalingam, S Novello, SZ Guclu, D Bentsion, Z Zvirbule, M Szilasi, R Bernabe, K Syrigos, LA Byers, P Clingan, J Bar, EE Vokes, R Govindan, M Dunbar, P Ansell, L He, X Huang, V Sehgal, J Glasgow, BA Bach, J Mazieres

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading